Status:
COMPLETED
HIP: HIV Intervention for Providers
Lead Sponsor:
Centers for Disease Control and Prevention
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose is to encourage Provider participants to evaluate high risk HIV transmission behaviors and offer prevention messages to their HIV+ patients which will, in turn, reduce rates of unprotected...
Eligibility Criteria
Inclusion
- Provider participants: (1) licensed MD, NP or PA on staff at the participating institution; (2) has a minimum panel of 5 HIV+ patients; (3) sees patients at least one-half day per week in the clinical setting; (4) is willing to participate in all intervention training sessions; and (5) is willing and able to provide full informed consent.
- HIV+ patient participants:(1) report at least 1 encounter of unprotected anal or vaginal sex with known HIV- or unknown serostatus partner in the preceding six months; (2) patient's Primary Provider is enrolled as a participant in the study; (3) age 18 years or older; and (4) willing and able to provide informed consent.
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00164398
Start Date
June 1 2004
End Date
September 1 2008
Last Update
September 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco - CAPS
San Francisco, California, United States, 94105